CompoAtlas

MegaRed

MegaRed, licence 80030824: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Reckitt Benckiser (Canada) Inc.
NPN or DIN-HM
80030824
Status
Active licence
Licence date
26 March 2012
Revision date
10 December 2014
Form
Capsule, molle
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de krill

Source : Euphausia superba oil (body)

Potency : 90.0 mg Omega-3 Fatty acids

300.0 mgNot calculated
Huile de krill

Source : Euphausia superba oil (body)

Potency : 50.0 mg EPA

Not specifiedNot calculated
Huile de krill

Source : Euphausia superba oil (body)

Potency : 24.0 mg DHA

Not specifiedNot calculated
Huile de krill

Source : Euphausia superba oil (body)

Potency : 130.0 mg Phospholipids

Not specifiedNot calculated

Non-medicinal ingredients

Glycérine, Ethyl Vanillin, Gélatine, Eau, Sorbitol

PopulationAgeQuantity per servingFrequency
AdultesNot specified2.0 Capsule1.0 Tous les jours
AdultesNot specified4.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of Omega-3 fatty acids (DHA/EPA) for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Megared has been shown to significantly increase your Omega-3 Index, a marker of cardiovascular health, in just 6 weeks. At 4 softgels daily: Clinically shown to help maintain / support cardiovascular health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80030824

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2014. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2014. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line